Ninety-four patients undergoing elective outpatient third molar extraction were recruited into a double-blind, randomized, prospective trial comparing mivacurium (group M) with succinylcholine (Group S) for conditions for endotracheal intubation and the occurrence of postoperative myalgia. Anaesthesia was induced with fentanyl 1 µg.kg -1 and propofol 2.5 mg.kg -1 in all patients. Group S patients were given gallamine 20 mg while group M patients were given mivacurium 0.2 mg.kg -1 . Manual ventilation was commenced and anaesthesia maintained with nitrous oxide 70% and isoflurane 1 to 2% in oxygen. After two minutes, group S patients were given succinylcholine 1.5 mg.kg -1 and group M patients 0.9% saline. Nasotracheal intubation was performed 30 seconds later. Intubating conditions in group M were significantly better than those in group S (P<0.001). The incidence of postoperative myalgia was 9.5% in group M and 26% in group S but this was not statistically significant (P=0.09). We propose that mivacurium is a suitable neuromuscular blocker to use for endotracheal intubation in outpatient dental surgery.
Third molar (wisdom tooth) extraction usually involves intubation of the trachea requiring the use of neuromuscular blocking agents. Due to the relative brevity of the surgery, a short-acting agent is suitable and therefore the obvious choice would be between succinylcholine and mivacurium. Each drug has advantages over the other in certain respects.
Succinylcholine is the only commonly used depolarizing neuromuscular blocker and is regarded by many as providing rapid optimal intubation conditions 1, 2 . Although the optimal dose is contentious, 1.5 mg.kg -1 is commonly employed. One major disadvantage associated with succinylcholine is postoperative myalgia, the incidence of which may vary with dose [3] [4] [5] . Pre-treatment with non-depolarizing neuromuscular blockers (NDNMBs) or concurrent administration of diazepam or lignocaine seem to be consistently effective [5] [6] [7] [8] at reducing this myalgia. Nonsteroidal anti-inflammatory drugs and propofol may also have a beneficial effect 9, 10 .
Mivacurium is a relatively recently introduced NDNMB whose exact niche in anaesthesia has not yet been fully established. The original recommended dose (0.1 to 0.15 mg.kg -1 ) may have been insufficient for intubation and it has been suggested that it is inferior to succinylcholine in this arena 1, 2 . It has been shown to be effective at doses of 0.15 to 0.19 mg.kg -1 11 . One advantage of mivacurium would be the potential absence of postoperative myalgia 12, 13 . In the context of daycase surgery this is a very important component of overall patient well-being in the days after discharge. It might also be expected that the relatively young age of daycase patients and early mobilization predisposes them to a higher incidence of myalgia in comparison to the general surgical population. Thus a major source of morbidity may be reduced. The aim of this study was to compare these two drugs when used in outpatient dental surgery with respect to both conditions for endotracheal intubation and the incidence and severity of postoperative myalgia.
MATERIALS AND METHODS
Ninety-four patients undergoing elective outpatient third molar extraction were recruited after obtaining local Ethics Committee approval and informed consent. Inclusion criteria were age 18 to 65 years, weight less than 110 kg, ASA 1 or 2, contactable by telephone and ability to give informed consent. Randomization was by computer-generated list.
In the anaesthetic room, intravenous access and monitoring (ECG, SpO 2 and non-invasive blood pressure) were established. Anaesthesia was induced with fentanyl 1 µg.kg -1 and propofol 2.5 mg.kg -1 . At the same time group S patients were given gallamine 20 mg while group M patients received mivacurium 0.2 mg.kg -1 , both syringes made up to 10 ml by an investigator not involved in the assessments. Manual ventilation to normocapnia (end-tidal P a CO 2 4 to 5.5 kPa) was commenced, anaesthesia being maintained with nitrous oxide 70% and isoflurane 1 to 2% in oxygen. After two minutes group S patients were given succinylcholine 1.5 mg.kg -1 and group M patients 0.9% saline, again both syringes made up to 10 ml. The intubator was instructed not to look at the patient for 30 seconds after the second injection so that any muscle fasciculation would not lead to unblinding. A second anaesthetist ensured continual visual assessment during this period. Thirty seconds later nasotracheal intubation under direct vision was performed by a consultant anaesthetist blinded to the patient's grouping. A throat pack was then inserted. All patients received diclofenac 100 mg pr in the anaesthetic room. The patients were initially mechanically ventilated and then allowed to breathe spontaneously when capable (assessment clinically and by train-of-four count). Lignocaine 2% with adrenaline 1/200,000 was injected locally at the end of the procedure by the consultant maxillofacial surgeon. The same surgeon operated on all patients.
Conditions for intubation were graded by the anaesthetist as excellent (no patient response), good (mild response not interfering with ease of intubation), or poor (marked response increasing the difficulty of intubation). This is an adapted version of a previously used scoring system 14 . Following return to the day unit, each patient was asked, when suitably recovered, to complete a questionnaire enquiring about the presence or absence of sore throat, headache, nausea, vomiting and oral pain.
On the third postoperative day patients were telephoned by an investigator not involved in the earlier stages of the study, and enquiries were made about general health and general pains in addition to the questions asked in the day unit questionnaire.
Patient demography, intubation conditions, number of teeth removed, duration of operation and general health were analysed using Mann-Whitney U test. All other components of the questionnaires including myalgia were compared using Chi-squared test with continuity correction for small numbers. P<0.05 was considered to be statistically significant. Correlation and linear regression analysis was carried out between myalgia occurrence and demographic data, number of teeth removed and duration of surgery. All analyses were carried out in SPSS 7.5 for Windows 95.
Our sample size of 94 patients gave an 80% chance of detecting a difference in myalgia incidence of 80% 15 . Assuming a minimum incidence in group S of 25%, then an incidence of 5% or less in group M would be statistically significant. We based these estimates on previously quoted myalgia rates greater than 25% for succinylcholine 8 and 0% for mivacurium 13 .
RESULTS
There were no significant differences in patient characteristics. The mean age (years) in group S was 24 (range: 18 to 62) and in group M 25 (range: 17 to 41). The mean weight (kg) in group S was 65 (range: 50 to 101) and 65 (45 to 105) in group M. There were 15 male and 32 female patients in each group. The number of teeth removed did not differ significantly between the groups-one tooth (group S=4, group M=3), two teeth (S=11, M=12), three teeth (S=5, M=8), four teeth (S=26, M=23) and five teeth (S=1, M=1). The median duration of surgery was 15 min (range: 8 to 25) in group S and 18 min (range: 5 to 32) in group M.
When excellent and good conditions at intubation were compared, group M was found to have a significantly greater number of excellent conditions (P<0.001, Table 1 ). The odds ratio was 10.5 (95% confidence intervals 3.4 to 32.5) with an incidence difference in excellent conditions of 41% (95% confidence intervals 24.1 to 57.9).
Forty completed day bed unit questionnaires were available from group S and 41 from group M. No significant differences were detected in the incidence of sore throat, nausea, vomiting, headache or oral pain ( Table 2 ). Forty-three patients were able to be contacted postoperatively by phone in group S and 42 in group M. There was no significant difference in general health, the incidence of nausea, vomiting or myalgia in the first three postoperative days (Table 3 ). Eleven patients reported myalgia in group S (26%) of whom seven were female. In group M, four patients (9.5%) reported myalgia of whom three were female. The 95% confidence intervals for the incidence difference were 0.7 to 26.1%. The odds ratio for myalgia was 3.28 (95% confidence intervals 0.49 to 21.7) with no significant difference in incidence between the groups (P=0.09). Median duration of myalgia in both groups was two days, the worst day was day 1 in group S and day 2 in group M. Table 4 shows the number of patients affected according to body part.
DISCUSSION
Succinylcholine remains the drug of choice for rapid onset of neuromuscular block. However, for elective procedures its side-effect profile renders it less attractive. The use of mivacurium for short duration procedures could, with slower onset, produce comparable intubating conditions, not require reversal of neuromuscular block due to its rapid breakdown by plasma cholinesterase and have a lower incidence of myalgia.
In our study, mivacurium provided better intubating conditions than succcinylcholine. This statistically significant difference in excellent conditions for intubation in group M was surprising. Previous work has either shown comparable conditions 19 or succinylcholine to be superior 1, 2, 13 . The currently recommended dose for mivacurium is 0.2 mg.kg -1 . There have, however, been contrasting findings in the literature in this area. No difference in intubating conditions was reported between mivacurium 0.11, 0.15 and 0.19 mg.kg -1 20 , with an overall rate of 83% with good or excellent conditions. This contrasts with the 98% (46/47) of our patients given mivacurium having excellent or good intubation conditions, and the report that mivacurium 0.15 mg.kg -1 was inadequate and that a 2.5 minute wait after 0.2 mg.kg -1 was required to reach 80% acceptability 2 . This compared poorly with succinylcholine where 100% of patients had acceptable conditions at one minute. A number of papers have found good conditions for intubation after mivacurium with a range of doses: 0.15 mg.kg -1 at two to three minutes 19 , 0.15 mg.kg -1 at three minutes 22 , 0.15, 0.17 and 0.19 mg.kg -1 11 , and 0.2 and 0.25 mg.kg -1 23 . It seems safe to conclude that higher doses of mivacurium (0.2 or more mg.kg -1 ) do produce good conditions for endotracheal intubation.
Overall 94% (44/47) of patients in group S had good to excellent conditions for intubation. This was not statistically different from that found in group M but there were significantly fewer excellent grades. This may be due to the effect of precurarization which can reduce the effectiveness of subsequently administered succinylcholine. A wide range of doses of succinylcholine have been studied with conflicting results. Succinylcholine 0.25 mg.kg -1 was shown to be as effective as 0.5 mg.kg -1 3 , although 1.5 mg.kg -1 and 3 mg.kg -1 were both found to be better than 0.5 mg.kg -1 with no significant difference between the two higher doses 24 . Similarly 0.25 and 0.5 mg.kg -1 were not only inferior to 1 mg.kg -1 but also inferior when compared with mivacurium 0.2 mg.kg -1 22 . The ultimate selection of dose may be based on the assumption that lower doses produce less myalgia but this has been dismissed by some reviewers 5 .
Two patients given mivacurium (4.2%) required reversal with neostigmine after confirmation that they both belonged to group M. This did not affect blinding as grading of intubation had already been made and the anaesthetist for the operation was not involved in follow-up assessment. The first may be attributable to the relative brevity of the operation lasting only 12 minutes compared to a median value of 18 minutes in that group. The second patient had an even shorter operation lasting only 11 minutes and neostigmine was administered due to poor respiratory effort and demonstration of residual paralysis on nerve stimulation. It is possible that this patient may have an abnormal plasma cholinesterase level. Succinylcholine is classically associated with myalgia, the incidence of which may vary from as low as 10% 22 up to 76.5% 9 . There have been many techniques developed in an attempt to reduce this rate, the most successful of which appears to be precurarization with the non-depolarizing neuromuscular blockers tubocurarine 8 , gallamine 8 and more recently rocuronium 21 . Recently a low incidence of post-succinylcholine myalgia, 10%, was reported following doses of 0.5 -1 mg.kg -1 without precurarization for a variety of maxillofacial operations 22 . This was attributed to a combination of a predominantly male sample, use of indomethacin and assessment only up to 24 hours post surgery. We chose to use gallamine as a precurarization agent as it has proven efficacy in this area and is much less likely to release histamine than tubocurarine.
The finding of a myalgia incidence in group S of 26% is consistent with other studies using precurarization. In these studies the incidence was reduced to 20% 7 and 30% 8 following the use of a precurarization regimen. An incidence of 9.5% in group M was higher than expected and may in some part be due to the nature of the surgery. It has been shown that myalgia may occur in dental surgery in the absence of any neuromuscular blocker 3 . Although non-steroidal drugs may reduce the incidence of myalgia 9 , this was not thought to bias our results as the overall dose-to-weight ratio was equal in both groups. The equal sex distribution in our groups meant that the greater incidence of myalgia in females did not affect our overall results.
NDNMBs can produce a reduction in myalgia occurrence by an average of 30% 5 although up to 70% reduction has been reported 16 . Although non-depolarizing agents are not usually associated with myalgia, a similar incidence of myalgia for succinylcholine, with precurarization, and vecuronium 17 has been shown following laparoscopic surgery. The authors suggested that vecuronium may be associated with myalgia although laparoscopy itself has been shown to produce myalgia in the absence of neuromuscular blockers 18 . Their study did not contain a control group for comparison. As mivacurium has not been associated with myalgia, we attempted to show that in this population mivacurium is a suitable alternative to succinylcholine in dental outpatient surgery for neuromuscular blockade.
Day bed unit questionnaires were used to compare general well-being between groups within a few hours of the operation and also to reduce patient bias by not asking solely about myalgia. It was decided to use telephone questionnaires in order to increase the response rate by not relying on patient initiative to return the form. The best time for follow-up is difficult to gauge, as myalgia duration can vary from 48 hours 10 to more than five days 3 . We considered that three days would detect true positives whilst minimizing false negatives. Some patients in group S did report symptoms on day 3 but none did in group M. It appears that myalgia was relatively short-lived in all patients affected. In only two patients (13%) were analgesics taken specifically for myalgia and both had been given succinylcholine. Though not statistically significant, this is suggestive that the intensity of myalgia may have been greater after suxamethonium. We believe that it is unlikely that mivacurium was a cause of myalgia and the type of surgery may be more important. It is likely that a larger sample size would have demonstrated a statistically significant difference incidence of myalgia, as our power calculation was based on a lower predicted incidence of myalgia in the mivacurium group.
The follow-up rate for telephone questionnaires was 90% (85/94). Data was recorded as missing if a subject was still unable to be contacted after three attempts by telephone. It could be suggested that this method is subject to more investigator bias, but we feel this is not so, as the follow-up investigator was blinded to patient grouping.
In conclusion we have demonstrated in a young, healthy population undergoing elective outpatient third molar extraction under general anaesthetic, that mivacurium is a suitable agent to use to facilitate endotracheal intubation. After 2 1 ¼2 minutes using 0.2 mg.kg -1 it provides comparable conditions for intubation to succinylcholine and in the majority of cases did not require reversal with neostigmine. The incidence of myalgia after mivacurium was lower than with suxamethonium, though not statistically significantly in this study. We suspect the modest, but higher than expected, incidence of myalgia after mivacurium relates to the type of surgery.
